Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 45 min ago
PreprintAll rights reservedbioRxiv

CD24-dependent innate immune checkpoint targeting chimera disrupts TGF-β-driven immunosuppression to enhance anti-tumor therapy

  • Z. Cui
  • Z. Lu
  • M. Pan
  • Y. Hu
  • M. Gao
  • A. Ma
  • Y. Hong
  • B. Wang
  • J. Zhang1
  • Y. Zhang1
  • X. Chen
  1. 1China Pharmaceutical University - Jiangning Campus
Read full textPDFDOICite

Related

  1. HLA-DR modulation and PD-1/PD-L2 checkpoint signaling identify a mechanistic potency axis for mesenchymal stromal cell immunosuppression
    Mahin Nikougoftar Zarif, Katia Lefsihane, Neda Khanlarkhani +4
    Stem Cells Translational MedicinePeer-reviewedCC BY 4.0Full textCell biologyPMC
  2. Gαi3 acts as a metabolic checkpoint orchestrating TAMs immunosuppression and lipid metabolism in glucose-deprived hepatocellular carcinoma
    Meixi Lu, Yaoyao Li, Siyu Du +11
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BY-NC 4.0Full textImmunologyDOAJPMC
  3. Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma
    Emily Steffke, Taijun Hana, Laila Latifi +15
    bioRxivPreprintAll rights reservedFull textImmunologybioRxivPMC
  4. Doublecortin mutation disrupts lattice-dependent proximity to reveal cytoskeletal networks in developing neurons
    B. L. Kelly, J. A. G. Haineault, L. M. Munter +2
    bioRxivPreprintAll rights reservedFull textDevelopmental biologybioRxiv
  5. MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice
    Juliana H. Azambuja, Saigopalakrishna S. Yerneni, Lisa M. Maurer +21
    Nature CommunicationsPeer-reviewedCC BY-NC-ND5 citedImmunologyOpenAlex

Cite

BibTeXRIS
BibTeX
@misc{cui2026cd24dependent,
  title = {{CD24-dependent innate immune checkpoint targeting chimera disrupts TGF-β-driven immunosuppression to enhance anti-tumor therapy}},
  author = {Z. Cui and Z. Lu and M. Pan and Y. Hu and M. Gao and A. Ma and Y. Hong and B. Wang and J. Zhang and Y. Zhang and X. Chen},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.754107},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.754107v1},
}
RIS
TY  - UNPB
TI  - CD24-dependent innate immune checkpoint targeting chimera disrupts TGF-β-driven immunosuppression to enhance anti-tumor therapy
AU  - Z. Cui
AU  - Z. Lu
AU  - M. Pan
AU  - Y. Hu
AU  - M. Gao
AU  - A. Ma
AU  - Y. Hong
AU  - B. Wang
AU  - J. Zhang
AU  - Y. Zhang
AU  - X. Chen
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.754107
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.754107v1
ER  -